Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Lung Cancer

In brief

This purpose of this study is to evaluate the role of gemcitabine and docetaxel, a well tolerated chemotherapy regimen in the treatment of advanced non-small cell lung cancer (NSCLC), in combination with a novel agent cetuximab.

Key facts

Study ID

NCT00193453

Run by

SCRI Development Innovations, LLC

People needed

69

Starts

2005-07-01

Expected to finish

2009-12-01

Last updated by the study team

2012-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be included in the study, you must meet the following criteria:
• 18 years of age or older
• Non-small cell lung cancer confirmed by biopsy
• Unresectable stage III or IV disease
• Measurable disease
• Must not have received any prior chemotherapy for lung cancer
• Able to perform activities of daily living without considerable assistance
• Adequate bone marrow, kidney, and liver function
• Signed informed consent

You may not qualify if…

• You cannot participate in the study if any of the following apply to you:
• History of serious heart disease within six months prior to study entry
• Prior treatment with agents that target the EGFR pathway
• History of any other uncontrolled or significant disease
• Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have. You can then decide if you wish to participate.

Where it is running

• Northeast Alabama Regional Medical Center — Anniston, Alabama, United States
• Northeast Arkansas Clinic — Jonesboro, Arkansas, United States
• Florida Cancer Specialists — Fort Myers, Florida, United States
• Gainsville Hematology Oncology Associates — Gainesville, Florida, United States
• Northeast Georgia Medical Center — Gainesville, Georgia, United States
• Graves-Gilbert Clinic — Bowling Green, Kentucky, United States
• Consultants in Blood Disorders and Cancer — Louisville, Kentucky, United States
• Mercy Hospital — Portland, Maine, United States
• Consultants in Medical Oncology and Hematology — Drexel Hill, Pennsylvania, United States
• Tennessee Oncology, PLLC — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.